Correlations between changes in disability and T2-weighted brain mri activity in multiple sclerosis: A follow-up study

Neurology

Volumn 45, Issue 2, 1995, Pages 255-260

  Filippi, M ^a   Paty, D W ^b   Kappos, L ^c,d   Barkhof, F ^e   Compston, D ^f   Thompson, A J ^a   Zhao, G J ^b   Wiles, C M ^g   McDonald, W I ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Neurologische Universitatsklinik Basel   (Switzerland)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHISOPRINOL;

ADULT; ARTICLE; DISABILITY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANALYSIS OF VARIANCE; BRAIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0028815032     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.45.2.255     Document Type: Article

References (27)

1. Lukes SA, Crooks LE, Aminoff MJ, et al. Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol 1983;13:592-601.
2. Gebarski SS, Gabrielsen TO, Gilman S, et al. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol 1985;17:469-474.
3. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992;18:319-334.
4. McDonald WI. The dynamics of multiple sclerosis. J Neurol 1993;240:28-36.
5. Koopmans RA, Li DKB, Grochowski E, et al. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989;25:74-81.
6. Baumhefner RW, Tourtellotte WW, Syndulko K, et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging: its correlation with clinical parameters, evoked potentials and intrablood-brain-barrier IgG synthesis. Arch Neurol 1990;47:19-26.
7. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance study. BMJ 1990;300:631-634.
8. Isaac C, Li DKB, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38: 1511-1515.
9. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium-enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-939.
10. Willoughby EW, Grochowski E, Li DKB, et al. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989;25:43-49.
11. Kermode AG, Tofts PS, Thompson AJ, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990;40:229-235.
12. Harris JO, Frank JA, Patronas N, et al. Serial gadolinium- enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-555.
13. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
14. Thompson AJ, Miller D, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63.
15. Wiebe S, Lee DH, Karlik SJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992;32:643-650.
16. Capra R, Marciano N, Vignolo LA, et al. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing-remitting multiple sclerosis. Arch Neurol 1992;49:687-689.
17. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637.
18. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull 1977;33:4-9.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
20. Paty DW, Li DKB UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebocontrolled trial. Neurology 1993;43:662-667.
21. Wiles CM, Omar L, Swan AV, et al. Total lymphoid irradiation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1994;57:154-163.
22. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC the Canadian Cooperative MS Study Group. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial. Neurology 1990;40:971-975.
23. Morrissey SP, Miller DH, Kendall BE, et al. Prognostic significance of brain MRI at presentation with a clinically isolated syndrome suggestive of MS: a five-year follow-up study. Brain 1993;116:135-146.
24. Filippi M, Horsfield MA, Morrissey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994;44:635-641.
25. Filippi M, Barker GJ, Horsfield MA, et al. A quantitative brain MRI study in benign and secondary progressive multiple sclerosis. J Neurol 1994;241:246-251.
26. Gass A, Barker GJ, Kidd D, et al. Magnetization transfer rate correlates with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-67.
27. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of the disease. Magn Reson Med 1990;14:154-159.